These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 26631686)
1. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study. Lu Y; Ren J; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B; Xinsheng L Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):333-40. PubMed ID: 26631686 [TBL] [Abstract][Full Text] [Related]
2. Effects of acupuncture at HT7 on glucose metabolism in a rat model of Alzheimer's disease: an 18F-FDG-PET study. Lai X; Ren J; Lu Y; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B Acupunct Med; 2016 Jun; 34(3):215-22. PubMed ID: 26654890 [TBL] [Abstract][Full Text] [Related]
3. Cerebral Responses to Acupuncture at GV24 and Bilateral GB13 in Rat Models of Alzheimer's Disease. Cui S; Xu M; Huang J; Wang QM; Lai X; Nie B; Shan B; Luo X; Wong J; Tang C Behav Neurol; 2018; 2018():8740284. PubMed ID: 29854022 [TBL] [Abstract][Full Text] [Related]
4. The functional neuroanatomy of verbal memory in Alzheimer's disease: [ Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444 [TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study. de Paula Faria D; Estessi de Souza L; Duran FLS; Buchpiguel CA; Britto LR; Crippa JAS; Filho GB; Real CC Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163003 [TBL] [Abstract][Full Text] [Related]
6. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging. Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease. Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635 [TBL] [Abstract][Full Text] [Related]
9. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]
10. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550 [TBL] [Abstract][Full Text] [Related]
11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246 [TBL] [Abstract][Full Text] [Related]
12. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity]. Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383 [TBL] [Abstract][Full Text] [Related]
13. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628 [TBL] [Abstract][Full Text] [Related]
14. Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [ Liu J; Yu J; Liu HB; Yao Q; Zhang Y Ann Nucl Med; 2022 Dec; 36(12):1019-1030. PubMed ID: 36178570 [TBL] [Abstract][Full Text] [Related]
15. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses. Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248 [TBL] [Abstract][Full Text] [Related]
16. Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice. Xiao NA; Zhang J; Zhou M; Wei Z; Wu XL; Dai XM; Zhu YG; Chen XC Chin Med J (Engl); 2015 Aug; 128(16):2220-7. PubMed ID: 26265617 [TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820 [TBL] [Abstract][Full Text] [Related]
19. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment]. Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368 [TBL] [Abstract][Full Text] [Related]
20. [Application of positron emission tomography in evaluation of Alzheimer's disease rat model]. He TT; Zhang JM; Wang RM; Yao SL; Tian JH Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):924-7. PubMed ID: 20646515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]